Benitec Biopharma (BNTC) closed at $7.92 on November 20, 2026, down 2.8% from the previous close, on volume of 265,002 shares (30-day average 174,843).
Data as of November 20, 2026.
Benitec Biopharma (BNTC) Gets a Buy from Leerink Partners
TipRanks (Mon, 16-Nov 8:36 AM ET)
Globe Newswire (Fri, 13-Nov 9:12 AM ET)
Globe Newswire (Fri, 13-Nov 8:00 AM ET)
Globe Newswire (Wed, 28-Oct 8:00 AM ET)
Globe Newswire (Mon, 5-Oct 8:00 AM ET)
Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update
Globe Newswire (Mon, 14-Sep 4:00 PM ET)
Market Chameleon (Mon, 12-Jan 2:10 AM ET)
Market Chameleon (Mon, 3-Nov 2:36 AM ET)
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.
Benitec Biopharma trades on the NASDAQ stock market under the symbol BNTC.
As of November 20, 2026, BNTC stock price declined to $7.91 with 265,002 million shares trading.
BNTC has a beta of 1.56, meaning it tends to be more sensitive to market movements. BNTC has a correlation of 0.12 to the broad based SPY ETF.
BNTC has a market cap of $285.88 million. This is considered a Small Cap stock.
In the last 3 years, BNTC traded as high as $17.15 and as low as $2.69.
The top ETF exchange traded funds that BNTC belongs to (by Net Assets): PINK, VTI, IWM, VXF, IWN.
BNTC has underperformed the market in the last year with a price return of -39.6% while the SPY ETF gained +5.2%. BNTC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -40.8% and -8.4%, respectively, while the SPY returned -10.1% and -5.9%, respectively.
BNTC support price is $7.71 and resistance is $8.57 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BNTC shares will trade within this expected range on the day.